Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Eyevance Pharmaceuticals acquires global rights for Nexagon from OcuNexus Therapeutics Eyevance Pharmaceuticals has made a significant move in the ophthalmic drug market by acquiring the global licensing rights… bypharmanewsdailyOctober 3, 2018